Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 31 to 33 of 33 results for enzalutamide

  1. Enzalutamide for the treatment of hormone refractory prostate cancer TA316

    Discontinued [GID-TA10267]

    Technology appraisal guidance
    Discontinued

  2. Apalutamide for treating non-metastatic, hormone-relapsed prostate cancer [ID1174]

    Discontinued [GID-TA10377]

    Technology appraisal guidance
    Discontinued

  3. Research recommendations

    manufacturer's ongoing commitment to collect data on the effectiveness of enzalutamide after previous treatment with abiraterone.